Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Total Liabilities 2010-2025 | AMRX

AMNEAL PHARMACEUTICALS, INC total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  
AMNEAL PHARMACEUTICALS, INC Annual Total Liabilities
(Millions of US $)
2024 $3,611
2023 $3,453
2022 $3,615
2021 $3,573
2020 $3,661
2019 $3,319
2018 $3,456
2017 $1,717
2016 $1,199
2015 $860
2014 $191
2013 $187
2012 $173
2011 $191
2010 $185
2009 $439
AMNEAL PHARMACEUTICALS, INC Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $3,497
2024-12-31 $3,611
2024-09-30 $3,555
2024-06-30 $3,567
2024-03-31 $3,520
2023-12-31 $3,453
2023-09-30 $3,533
2023-06-30 $3,550
2023-03-31 $3,492
2022-12-31 $3,615
2022-09-30 $3,680
2022-06-30 $3,868
2022-03-31 $3,482
2021-12-31 $3,573
2021-09-30 $3,591
2021-06-30 $3,633
2021-03-31 $3,593
2020-12-31 $3,661
2020-09-30 $3,689
2020-06-30 $3,686
2020-03-31 $3,987
2019-12-31 $3,319
2019-09-30 $3,308
2019-06-30 $3,513
2019-03-31 $3,585
2018-12-31 $3,456
2018-09-30 $3,667
2018-06-30 $3,605
2018-03-31 $1,161
2017-12-31 $1,717
2017-09-30 $1,167
2017-06-30 $1,176
2017-03-31 $1,155
2016-12-31 $1,199
2016-09-30 $1,216
2016-06-30 $777
2016-03-31 $817
2015-12-31 $860
2015-09-30 $967
2015-06-30 $1,045
2015-03-31 $888
2014-12-31 $191
2014-09-30 $204
2014-06-30 $190
2014-03-31 $157
2013-12-31 $187
2013-09-30 $196
2013-06-30 $198
2013-03-31 $210
2012-12-31 $173
2012-09-30 $220
2012-06-30 $309
2012-03-31 $277
2011-12-31 $191
2011-09-30 $176
2011-06-30 $187
2011-03-31 $185
2010-12-31 $185
2010-09-30 $219
2010-06-30 $441
2010-03-31 $483
2009-12-31 $439
2009-09-30 $349
2009-06-30 $345
2009-03-31 $349
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.244B $2.794B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.587B 32.48
Zoetis (ZTS) United States $72.382B 27.01
Daiichi Sankyo, - (DSNKY) Japan $50.265B 25.57
Takeda Pharmaceutical (TAK) Japan $46.360B 9.22
Sandoz Group AG (SDZNY) Switzerland $21.683B 0.00
Summit Therapeutics (SMMT) United States $19.198B 0.00
Merck (MKKGY) Germany $16.795B 12.31
United Therapeutics (UTHR) United States $13.877B 12.28
Shionogi (SGIOY) Japan $13.799B 0.00
Neurocrine Biosciences (NBIX) United States $11.894B 40.74
IPSEN (IPSEY) France $9.790B 0.00
Orion OYJ (ORINY) Finland $9.323B 25.21
Corcept Therapeutics (CORT) United States $8.345B 67.84
Stevanato Group S.p.A (STVN) Italy $6.756B 41.31
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.941B 0.00
Grifols, S.A (GRFS) Spain $5.576B 0.00
Ionis Pharmaceuticals (IONS) United States $5.249B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.875B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.987B 10.47
Crinetics Pharmaceuticals (CRNX) United States $2.786B 0.00
Hypermarcas (HYPMY) Brazil $2.616B 17.21
BioCryst Pharmaceuticals (BCRX) United States $2.216B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.977B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.719B 0.00
Evotec AG (EVO) Germany $1.680B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.659B 0.00
Indivior (INDV) United States $1.553B 6.58
ARS Pharmaceuticals (SPRY) United States $1.471B 0.00
Guardian Pharmacy Services (GRDN) United States $1.389B 0.00
Dyne Therapeutics (DYN) United States $1.329B 0.00
Ocular Therapeutix (OCUL) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.092B 21.84
Harrow (HROW) United States $0.950B 0.00
Ardelyx (ARDX) United States $0.950B 0.00
Collegium Pharmaceutical (COLL) United States $0.927B 5.00
Avadel Pharmaceuticals (AVDL) Ireland $0.883B 0.00
Enliven Therapeutics (ELVN) United States $0.805B 0.00
Cronos Group (CRON) Canada $0.782B 0.00
Xeris Biopharma Holdings (XERS) United States $0.755B 0.00
Akebia Therapeutics (AKBA) United States $0.751B 0.00
AleAnna (ANNA) United States $0.675B 0.00
KalVista Pharmaceuticals (KALV) United States $0.570B 0.00
Elite Pharmaceuticals (ELTP) United States $0.566B 0.00
USANA Health Sciences (USNA) United States $0.548B 11.91
Regulus Therapeutics (RGLS) United States $0.546B 0.00
Xencor (XNCR) United States $0.539B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.499B 0.00
Savara (SVRA) United States $0.491B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.473B 0.00
Zevra Therapeutics (ZVRA) United States $0.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.465B 0.00
Altimmune (ALT) United States $0.463B 0.00
CytoDyn (CYDY) United States $0.424B 0.00
Siga Technologies (SIGA) United States $0.422B 8.82
Oruka Therapeutics (ORKA) United States $0.410B 0.00
Tourmaline Bio (TRML) United States $0.394B 0.00
Verve Therapeutics (VERV) United States $0.389B 0.00
Organogenesis (ORGO) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.339B 9.15
Heron Therapeutics (HRTX) United States $0.282B 0.00
Nature's Sunshine Products (NATR) United States $0.262B 24.19
Aquestive Therapeutics (AQST) United States $0.233B 0.00
MediWound (MDWD) Israel $0.220B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.212B 0.00
ProKidney (PROK) United States $0.208B 0.00
Nanobiotix S.A (NBTX) France $0.172B 0.00
Wellgistics Health (WGRX) United States $0.170B 0.00
OmniAb (OABI) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.166B 0.00
Journey Medical (DERM) United States $0.163B 0.00
4D Molecular Therapeutics (FDMT) United States $0.162B 0.00
Esperion Therapeutics (ESPR) United States $0.157B 0.00
Profound Medical (PROF) Canada $0.154B 0.00
Liminatus Pharma (LIMN) $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.133B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Korro Bio (KRRO) United States $0.130B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Lyell Immunopharma (LYEL) United States $0.123B 0.00
Nektar Therapeutics (NKTR) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
VAXART, INC (VXRT) United States $0.106B 0.00
Achieve Life Sciences (ACHV) Canada $0.105B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
Cardiol Therapeutics (CRDL) Canada $0.091B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.081B 0.00
Champions Oncology (CSBR) United States $0.080B 13.18
Pyxis Oncology (PYXS) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 56.44
ESSA Pharma (EPIX) Canada $0.075B 0.00
Inotiv (NOTV) United States $0.073B 0.00
Surrozen (SRZN) United States $0.068B 0.00
Dominari Holdings (DOMH) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.067B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Nutriband (NTRB) United States $0.061B 0.00
Metagenomi (MGX) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.047B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
FibroGen (FGEN) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.78
Ainos (AIMD) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00